What Is Dermatitis Herpetiformis?
Source: Genetic and Rare Diseases (GARD) Information Center
You can contact us here
Dermatitis Herpetiformis
DH; Duhring-Brocq Disease
Dermatitis herpetiformis (DH) is a chronic, intensely itchy, blistering skin manifestation of gluten-sensitive enteropathy, commonly known as celiac disease. DH is a rash that affects about 10 percent of people with celiac disease. DH is found mainly in adults and is more common in men and people of northern European descent. Learn more.
Micrograph of dermatitis herpetiformis
Image by Beatriz Di Martino Ortiz, Hugo Macchi, Celeste Valiente Rebull, María Lorena Re Dominguez, Guadalupe Barboza/Wikimedia
Dermatitis Herpetiforme 4
Image by BallenaBlanca/Wikimedia
Source: Genetic and Rare Diseases (GARD) Information Center
Rheumatoid Factor Molecules (IgM, IgG, and IgA)
Image by TheVisualMD
Dermatitis herpetiformis is caused by the deposit of immunoglobulin A (IgA) in the skin, which triggers further immunologic reactions resulting in lesion formation. DH is an external manifestation of an abnormal immune response to gluten, in which IgA antibodies form against the skin antigen epidermal transglutaminase.
Family studies show that 5 percent of first-degree relatives of a person with DH will also have DH. An additional 5 percent of first-degree relatives of a person with DH will have celiac disease. Various other autoimmune diseases are associated with DH, the most common being hypothyroidism.
Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Dermatitis Herpetiforme 5
Image by BallenaBlanca/Wikimedia
Dermatitis herpetiformis is characterized by small, clustered papules and vesicles that erupt symmetrically on the elbows, knees, buttocks, back, or scalp. The face and groin can also be involved. A burning sensation may precede lesion formation. Lesions are usually scratched off by the time a patient comes in for a physical exam, and the rash may appear as erosions and excoriations.
Patients with DH may also experience dental enamel defects to permanent teeth, which is another manifestation of celiac disease. Less than 20 percent of people with DH have symptoms of celiac disease.
Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Skin punch biopsy
Image by BruceBlaus
A skin biopsy is the first step in diagnosing DH. Direct immunofluorescence of clinically normal skin adjacent to a lesion shows granular IgA deposits in the upper dermis. Histology of lesional skin may show microabscesses containing neutrophils and eosinophils. However, histology may reveal only excoriation due to the intense itching that patients experience.
Blood tests for antiendomysial or anti-tissue transglutaminase antibodies may also suggest celiac disease. Blood tests for epidermal transglutaminase antibodies are positive in more than 90 percent of cases. All of these tests will become negative with prolonged adherence to a gluten-free diet.
A positive biopsy and serology confirm DH and should be taken as indirect evidence of small bowel damage. A biopsy of the small bowel is usually not needed for DH diagnosis. However, if clinical signs of gastrointestinal disease are evident on examination, further workup may be required. Whether or not intestinal damage is evident, a gluten-free diet should be implemented because the rash of DH is gluten sensitive.
Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Dapsona 50mg
Image by Docnoriega/Wikimedia
The sulfone dapsone can provide immediate relief of symptoms. For patients who cannot tolerate dapsone, sulfapyridine or sulfamethoxypyridazine may be used, although these medications are less effective than dapsone. A strict gluten-free diet is the only treatment for the underlying disease. Even with a gluten-free diet, medication therapy may need to be continued from a few months to 2 years.
DH can go into remission, which is defined as absence of skin lesions and symptoms of DH for more than 2 years while not taking sulfones or other treatments and not adhering to a gluten-free diet. Cohort studies showing DH remission provide support for reducing sulfone therapy and weaning from a gluten-free diet in patients with well-controlled DH.
Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Get free access to in-depth articles and track your personal health.
Send this HealthJournal to your friends or across your social medias.